Diagnostics News and Research

RSS

Federal and industry sponsors play complementary roles in cancer clinical trials

A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they have distinct, interdependent roles in cancer research.

20 Aug 2026

AI predicts vaccine response based on pre-existing antibody patterns

Vaccines protect most people from serious illness, but the strength of that protection can vary considerably from one person to another. A new study led by Arizona State University helps us understand why.

20 Aug 2026

Rapid test breakthrough could transform iron treatment worldwide

WEHI researchers have developed a blood test that can detect iron deficiency in minutes, overcoming key limitations of existing point-of-care diagnostics and potentially transforming how the condition is diagnosed and treated worldwide.

20 Aug 2026

AI-based "tissue clocks" measure the biological age of human organs

AI-based "tissue clocks" can estimate the biological age of human organs from histological images, researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Ludwig Boltzmann Institute for Network Medicine (LBI-NetMed) at the University of Vienna showed.

14 Aug 2026

Synthetic peptide enables modular detection of coronavirus protease activity

A research team has computationally designed a synthetic peptide that enables modular detection of the enzymatic activity of coronavirus 3C-like protease (3CLPro), an enzyme essential for viral replication and maturation.

13 Aug 2026

Personalized T-cell therapy eliminates advanced kidney tumor in teenager

Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor.

12 Aug 2026

New machine learning model improves accuracy of prenatal genetic testing

Advances in genome sequencing are giving more families access to prenatal genetic testing and new information about an unborn baby's health, including whether genetic changes may link to a neurodevelopmental condition.

11 Aug 2026

Leica Biosystems enables faster cancer diagnoses through multiple digital pathology FDA clearances, including industry-first AI-assisted quality control software

Leica Biosystems introduces AI-driven quality control in digital pathology, streamlining workflows and enhancing diagnostic accuracy for better patient care.

From Leica Biosystems 11 Aug 2026

New multi-protein blood test accurately detects late-stage Alzheimer's disease

Researchers have identified seven proteins in the blood that could enable better blood tests for Alzheimer's disease.

11 Aug 2026

Accelerating life science computing with AI-ready infrastructure

Discover how computing is transforming life science research through AI infrastructure, GPU acceleration, and genomics.

From Advantech 10 Aug 2026

New drug delivers promising survival gains in pancreatic cancer

About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating mutation in the KRAS gene.

9 Aug 2026

AI-powered blood test detects liver cancer across distinct populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

31 Jul 2026

Sino Biological launches SuperNuclease® Pro with free trial program

Sino Biological, Inc., a global leader in recombinant technology, announced the launch of SuperNuclease® Pro (Cat#: SSNP02).

From Sino Biological Inc. 31 Jul 2026

Waters launches industry's most sensitive and robust clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

The Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Meeting – Waters Corporation today announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding its MassTrak™ IVD System portfolio of LC-MS/MS Systems with a solution that combines class-leading sensitivity and enhanced robustness for clinical applications.

31 Jul 2026

Program introduces Florida students to virology and pandemic preparedness

Thirty outstanding high school students from 18 communities across Florida arrived in Tampa last week for the Global Virus Network (GVN) Global Guardians for Pandemic Preparedness Program, curious about viruses and considering careers in science.

30 Jul 2026

Lanthanide carriers advance next generation biomedical imaging and theranostics

Lanthanide carriers could help define the next generation of biomedical imaging and fast-track the emerging field of theranostics-approaches that link diagnostic imaging with treatment selection, delivery, or monitoring.

30 Jul 2026

INTEGRA Biosciences expands availability of MAGFLO™ NGS magnetic beads for efficient NGS size selection and PCR clean-up

MAGFLO NGS magnetic beads provide a cost-effective solution for nucleic acid purification, compatible with various fragment sizes and sequencing applications.

From INTEGRA Biosciences 30 Jul 2026

TGen joins Collaborative Research Network for Parkinson's disease research

The Translational Genomics Research Institute (TGen), part of City of Hope, today announced it has been selected as part of a national team to join the Collaborative Research Network (CRN), an international, multi-institutional initiative focused on addressing high-priority research questions in Parkinson's disease.

28 Jul 2026

Remdesivir protects kidney and heart health in transplant recipients

Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of COVID-19 diagnosis and who received at least three consecutive days of therapy were less likely than kidney transplant recipients who did not receive the antiviral to experience cardiovascular or kidney problems up to a year later, according to findings from a target trial emulation study that published in JAMA Network Open.

28 Jul 2026

Integration is key to fighting global epidemics, WHO reports

The World Health Organization (WHO) today launched a new report assessing progress in implementing the Global Health Sector Strategies (GHSS) on HIV, viral hepatitis and sexually transmitted infections (STIs) for 2022–2030.

28 Jul 2026